Others in its drug class like Wegovy, have also seen a surge in demand, one so high that the Food and Drug Administration has reported a national drug shortage for them
GLP-1 Receptor Agonist Market Report Scope & Overview: The GLP-1 Receptor Agonist Market was estimated at USD 60.6 billion in 2025 and is expected to reach USD 307 billion by 2035 and grow at a CAGR of 17.61% over the forecast period of 2026-2035
They know the risks that come with extra weight, including potential complications like kidney failure
Here are some options to discuss with your healthcare provider: Qsymia ( phentermine / topiramate ) is a daily oral medication that works by reducing appetite and binge eating behaviors
"With the socioeconomic constraints, the cost variables that are at play, we have huge concerns that a large percentage of our patient base that is reliant on compounded formularies that you can get for $100 to $200 a month and now they are faced with having to pay $1,000, we're concerned about where those patients are going to go," he said
Can I Switch From Semaglutide to Tirzepatide
